Elon Musk's Neuralink Gets Green Light for Human Trials of Brain Chip Implants
-
Neuralink, Elon Musk's brain implant startup, is set to begin human trials after receiving approval from an independent review board.
-
The first trial, called PRIME, will involve implanting chips in paralysis patients to allow them to control devices with their thoughts.
-
Patients with quadriplegia due to spinal cord injury or ALS may qualify for the 6-year study.
-
Neuralink aims to connect the human brain to computers but has only tested on animals so far.
-
The company received FDA clearance for human trials in May after initially being rejected over safety concerns.